Avsnitt
-
In this episode, Host Tom Salemi is joined by Darla Hutton, Intuitive’s global vice president of cardiac surgery, to discuss the surgical robotics giant’s return to cardiac surgery.
Intuitive famously aimed for the heart at its outset but pivoted when cardiac surgery proved too complicated. Today, heart patients and surgeons are pushing for minimally invasive procedures, and Hutton, a former cardiac surgery OR nurse, has been tapped to lead the company’s push into an increasingly competitive specialty.
But first, Harmonic Drive’s Bill Frey, regional sales engineer, joins us in the FOMO Studio. Go to HarmonicDrive.net for more information.
Filling in for MassDevice’s Chris Newmarker, Senior Editor Sean Whooley wraps up the five biggest stories to come out of the American Diabetes Association meeting — Abbott, Senseonics, Sequel, Dexcom, and Insulet.
***
Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.
Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe
Chapters(00:04:43) - Abbott studies reinforce DKA opportunity following dual sensor milestone(00:07:13) - Senseonics study supports Eversense 365 CGM with automated insulin delivery tech(00:09:20) - Sequel Med Tech data supports twiist automated insulin delivery in type 2 diabetes(00:11:18) - Dexcom study highlights benefits of G7 CGM in non-insulin type 2 diabetes(00:13:01) - Insulet data backs Omnipod 6, fully closed-loop AID systems(00:16:29) - FOMO Studio - Bill Frey, regional sales engineer, Harmonic Drive(00:27:14) - Keynote Interview - Darla Hutton, Global Vice President, Cardiac Surgery Intuitive -
In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi interviews Lisa Earnhardt, Executive Vice President and Group, President, Medical Devices, Abbott.
Earnhardt shared her views on Abbott’s advances in electrophysiology, pacemakers, and other technologies in this interview, which was conducted at DeviceTalks Minnesota.
In our sponsor interview ATL Medical CEO Jim Fitzgerald unpacks the meaning of its Manufacturing for Life philosophy with Managing Editor Kayleen Brown.
For more information go to www.ATLMedical.com. To find the blog mentioned in the interview, go here.
But we’ll start off with MassDevice Editor Chris Newmarker with this week’s Newsmakers – Philips, Disney, Neurovalens, Edwards, Insulet and Medtronic.
***
Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.
Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe
Chapters(00:06:00) - Philips, Disney partner to improve MRI experience for children(00:09:40) - Neurovalens earns FDA nod for neuromod for PTSD(00:12:55) - Edwards gets FDA nod for Triformis Resilia surgical tricuspid valve replacement(00:14:22) - Insulet initiates another Omnipod 5 recall affecting 7 million devices including some Dash, Eros systems(00:17:01) - Medtronic sees best revenue growth in 10 years, but overall Q4 mixed -
Saknas det avsnitt?
-
In this episode, the editorial team shares their highlights and lessons from two great days at DeviceTalks Boston.
Tom Salemi, Kayleen Brown, Chris Newmarker, Jim Hammerand, Sean Whooley and Skyler Rivera highlighted discussions on new technologies, personal stories, Boston’s ecosystem, and the power of MedTech. Joining them on the panel were special guests Saul Marquez of the Outcomes Rocket, Etienne Nichols of Greenlight Guru and Holly Scott of The Mullings Group.
3:51 – Happy Birthday Kayleen Brown!
5:13 – MassDevice Executive Editor Chris Newmarker – Power of the Personal Story
9:25 - Senior Editor Sean Whooley – Analyzing Boston’s exceptionalism
11:10 -Associate Editor Skyler Rivera – Women in MedTech breakfast
14:05 – DeviceTalks Managing Editor Kayleen Brown -Designing for Reality/ Flipping the Script
17:28 - MDO Managing Editor Jim Hammerand – News Team Assembled!
20:10 – Saul Marquez, Outcomes Rocket – Importance of Conferences
24:16 – Etienne Nichols, Greenlight Guru – Why Making a Difference Matters
28:22 –
32:10 – Tom Salem – We Must Pay it Forward, New MedTech modalities
***
Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.
Chapters(00:03:51) - Happy Birthday Kayleen Brown!(00:05:13) - MassDevice Executive Editor Chris Newmarker – Power of the Personal Story(00:09:25) - Senior Editor Sean Whooley – Analyzing Boston’s exceptionalism(00:11:10) - Associate Editor Skyler Rivera – Women in MedTech breakfast(00:14:05) - DeviceTalks Managing Editor Kayleen Brown -Designing for Reality/ Flipping the Script(00:17:28) - MDO Managing Editor Jim Hammerand – News Team Assembled!(00:20:10) - Saul Marquez, Outcomes Rocket – Importance of Conferences(00:26:16) - Etienne Nichols, Greenlight Guru – Why Making a Difference Matters(00:28:22) - Holly Scott, Senior Partner, The Mullings Group – Serendipity and MedTech Innovators(00:32:10) - Tom Salemi – We Must Pay it Forward, New MedTech modalities -
In this episode of DeviceTalks Weekly, Host Tom Salemi speaks with Axoft CEO and co-founder Paul Le Floch about the future of brain-computer interfaces and the material science breakthroughs powering the next generation of neural implants.
Le Floch shares how his background in materials science led to the development of “Fleuron,” Axoft’s soft, flexible implant material designed to better match the brain’s delicate tissue and reduce long-term damage caused by traditional rigid implants. The conversation explores the challenges facing the BCI industry, including device durability, signal stability, and the difficulty of commercializing implantable neurotechnology. Le Floch also discusses Axoft’s focus on treating disorders of consciousness, its collaboration with Mass General Hospital, the company’s recent $55 million Series A financing, and why Massachusetts remains both an ideal — and expensive — place to build a deep-tech MedTech startup.
In our FOMO Studio, Salemi sits down with MassMEDIC President Brian Johnson and Holly Scott of The Mullings Group to preview DeviceTalks Boston and explore the state of the Massachusetts MedTech ecosystem. Johnson reflects on MassMEDIC’s 30th anniversary, the evolution of DeviceTalks, and why Massachusetts remains one of the world’s leading hubs for medical technology innovation. The conversation covers the region’s deep strengths in robotics, orthopedics, organ transplantation, and cardiovascular technology, along with the challenges startups face in securing early-stage funding and navigating tariffs and manufacturing shifts.
And of course we start of with MassDevice Editor Chris Newmarker's top news from the pages of MassDevice - Cagent Vascular, BD, Medtronic, Johnson & Johnson MedTech, Endologix, Surmodics and Boston Scientific.
Join us May 27-28th at DeviceTalks Boston. Visit Boston.DeviceTalks.com for the full agenda and speakers.
***
Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.
Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe
Chapters(00:04:41) - Cagent Vascular reports first-in-human IVL cases, closes $41M Series D(00:06:31) - BD taps former J&J leader as new president of Interventional(00:10:09) - Endologix acquires Pounce thrombectomy system from Surmodics(00:11:32) - Medtronic to acquire peripheral nerve stim developer SPR Therapeutics(00:13:30) - Boston Scientific invests $1.5B in TAVR developer MiRus, enters $2B share repurchase agreement(00:18:15) - FOMO Studio – Brian Johnson, President, MassMEDIC and Holly Scott, Senior Partner, The Mullings Group(00:33:03) - Keynote Converation – Paul Le Floch, CEO, Axoft -
In this special DeviceTalks Weekly Podcast episode, Host Tom Salemi previews the biggest conversations, technologies, and innovators heading to DeviceTalks Boston on May 27–28 at the Boston Convention & Exhibition Center.
First, Tom Salemi and Mike Moore, partner at The Mullings Group, visits with Christian Howell, CEO of Cognito Therapeutics. Howell will be speaking at DeviceTalks Boston about the neuro company’s clinical, fund-raising and partnering success.
Howell also shares insights into Cognito’s partnerships with research institutions and the future of noninvasive therapies for neurodegenerative disease. He’ll be among the many speakers address Innovation & Investment at the conference, with others including the MedTech Innovator Open Rounds sessions and venture capital investors including Abby Hunter-Syed of Olympus Innovation Ventures and Maria Berkman, MD, of Vensana Capital.
Tom and Holly Scott also speak with Dr. Sarah Matt, author of Borderless Healthcare Revolution, about the challenges of connected health adoption and why many health-tech pilots fail to scale. Matt previews her DeviceTalks Boston panel examining the “physician veto” and the barriers device makers face when introducing new digital health technologies into clinical environments.
Several sessions at DeviceTalks Boston will address the challenges and opportunities of Connected Health including a keynote interview with Ashley McEvoy, CEO of Insulet, as well as presentations by Philips, Baxter and others.
The episode also features a wide-ranging conversation with Mullings Group leaders Mike Moore and Holly Scott about the strength of the Massachusetts medtech ecosystem, the growth of surgical robotics, and the importance of conferences in building meaningful industry relationships.
If you want to join us at DeviceTalks Boston, you can register at Boston.DeviceTalks.com. Use the code DTW25 to save 25% off the price of registration.
***
Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.
Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe
Chapters(00:03:40) - Mike Moore of The Mulling Group and Tom interview Christian Howell, CEO of Cognito Therapeutics(00:15:40) - Holly Scott of the Mullings Group and Tom interview Sarah Matt, MD, author of The Borderless Healthcare Revolution(00:22:30) - Holly, Mike and Tom breakdown the components of DeviceTalks Boston and the Massachusett.s MedTech industry -
In this episode of DeviceTalks Weekly, Tom Salemi talks with Wayne Allen, the co-founder and CEO of Perfuze, an Irish company developing a novel new way of blood clot aspiration. Allen and his co-founder already executed one successful exit earlier in their careers. Can they find success again with Perfuze?
This episode is sponsored by DeviceTalks Boston. Go to Boston.DeviceTalks.com to register. Use the code DTW25 to save 25%.
MassDevice Editor Chris Newmarker opens up the podcast with this week’s top stories from the pages of MassDevice – Masimo, Danaher, ResMed, Johnson & Johnson MedTech, and Medtronic.
***
Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.
Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe
Chapters(00:02:00) - Quick recap of DeviceTalks Minnesota(00:07:05) - MassDevice’s Orthopedic Device Companies Special Report for 2026(00:08:20) - Masimo shareholders give green light to $10B acquisition by Danaher(00:09:56) - ResMed enters merger agreement to acquire Noctrix Health for $340 million(00:14:03) - Johnson & Johnson says Ottava surgical robot met endpoints in pivotal bariatric surgery study(00:15:45) - Medtronic merges Cardiac Surgery, Aortic units into Cardiovascular Surgery business(00:19:45) - FOMO Studio – Yossi Bar, CEO, LEM Surgical(00:31:22) - Keynote Interview- Wayne Allen, CEO, Perfuze -
In this episode, Host Tom Salemi and Holly Scott, senior partner at The Mullings Group, preview the upcoming DeviceTalks Minnesota agenda. Join us on May 4 at the McNamara Alumni Center!
If you haven’t registered, use the code DTW25 to save 25% off the price of registration, visit https://minnesota.devicetalks.com/.
MassDevice Editor Chris Newmarker also delivers this week’s top newsmakers on the pages of MassDevice—HRS 2026, Johnson & Johnson, Stryker, Medtronic, and Teleflex.
***
Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.
Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe
Chapters(00:07:25) - The top cardiac tech stories out of HRS 2026(00:09:03) - Johnson & Johnson launches head-to-head PFA trial pitting Varipulse against Boston Scientific’s Farapulse(00:10:16) - Stryker results miss after Q1 cyberattack; company sticks with guidance(00:11:43) - Medtronic discloses cybersecurity breach in certain IT systems(00:15:30) - Teleflex picks Medtronic Coronary & Renal Denervation leader Weidman as new CEO -
In this episode of the DeviceTalks Weekly Podcast, SetPoint Medical CEO Murthy Simhambhatla gives listeners an audio glimpse of what attendees at DeviceTalks Minnesota will hear during the Bringing NeuroTechnologies to New Markets panel.
As he explains in this interview, Simhambhatla—an experienced MedTech executive—was initially skeptical of SetPoint’s potential after being invited to lead the company. But the more he read, the more he became convinced the vagal stimulator could help fight inflammation. “Cytokines don’t lie,” he said. Today, SetPoint Medical has FDA approval, is building a commercial plan, and is considering future financing, including a possible IPO.
This episode is sponsored by DeviceTalks Minnesota. Go to Minnesota.DeviceTalks.com to see the agenda. Remember to use the code DTM25 to save 25% on new registrations.
We also get a visit to our FOMO Studios from Saul Marquez, CEO of Outcome Rocket, a market research and end-to-end marketing execution agency that helps medtech and health tech organizations grow their impact and accelerate growth. See more and download the report we discuss here: https://www.outcomesrocket.com/
Finally, MassDevice Editor Chris Newmarker shares this week’s top newsmakers from MassDevice—Abbott, Johnson & Johnson MedTech, Boston Scientific, Medtronic, Pulnovo, and CathWorks.
***
Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe
Chapters(00:09:23) - 5 next-gen heart valve replacement companies you need to know(00:11:35) - Abbott completes enrollment in IVL study(00:13:50) - Johnson & Johnson MedTech to launch new AI module for EP mapping(00:15:10) - Boston Scientific cuts 2026 guidance despite Q1 beats(00:17:12) - Medtronic leads $100M financing for artery denervation tech developer Pulnovo Medical(00:18:20) - Medtronic completes $585M CathWorks acquisition(00:23:34) - FOMO Studio: Saul Marquez, CEO, Outcomes Rocket(00:38:19) - Keynote Conversation: SetPoint Medical CEO Murthy Simhambhatla -
In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi interviews Michael Carter, SVP, President, Cranial & Spinal Technologies about the company’s deployment of robotics, AI and other tech.
Managing Editor Kayleen Brown hosts Etienne Nichols, Head of Industry Insights & Education, Greenlight Guru, on this weeks’ FOMO.
MassDevice Editor Chris Newmarker highlights the MassDevice newsmakers – Stereotaxis, Robocath, Prosomnus, Johnson & Johnson MedTech, Avanos Medical, Stryker and Amplitude Vascular Systems.
Thanks to Greenlight Guru for sitting in our FOMO studio! Download its QMSR readiness playbook, it's everything you need to get compliant with QMSR, all in one place:
https://www.greenlight.guru/qmsr-readiness-playbook-free-downloadIf you haven’t registered for DeviceTalks Minnesota or DeviceTalks Boston, use the code DTW25 to save 25%
***
Chapters(00:01:25) - Discount code to attend DeviceTalks events(00:03:11) - Newmarker's Newsmakers(00:05:25) - Stereotaxis to acquire Robocath for up to $45M(00:09:02) - ProSomnus gets FDA nod for latest sleep apnea therapy device(00:12:08) - Johnson & Johnson ups 2026 outlook on Q1 beats, MedTech sales rise 7.7%(00:15:11) - Avanos Medical agrees to be acquired by private equity firm in $1.3B deal(00:16:22) - Stryker makes IVL play with agreement to acquire Amplitude Vascular Systems(00:18:36) - FOMO Guest: Etienne Nichols, Head of Industry Insights & Education, Greenlight Guru(00:31:55) - Keynote Interview- Michael Carter, SVP President, Cranial & Spinal Technologies, Medtronic
Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.
Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe -
In this episode of the DeviceTalks Weekly Podcast, OrthAlign CEO Eric Timko explains how he’s built two successful companies in the wake of surgical robotics’ rise in orthopedics. He also shares sage advice from his father—words that ultimately led him to a career in medical devices.
This episode is sponsored by DeviceTalks Minnesota. Register at Minnesota.DeviceTalks.com and use the code DTW25 to save 25% off registration.
In this week’s Newmarker’s Newsmakers, Host Tom Salemi shares his experience from MedTech Innovator’s Radar Forum. Then he and Chris Newmarker review the biggest news on MassDevice: Stryker, Johnson & Johnson MedTech, Intuitive, Baxter, and the Transcatheter Heart Valves Special Report.***
Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.
Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe
Chapters(00:02:30) - MedTech Innovator Radar Forum(00:09:30) - MassDevice’s Transcatheter Heart Valves Special Report(00:11:08) - Stryker operations fully restored after cyberattack(00:14:55) - Johnson & Johnson brings next-gen Varipulse PFA catheter to Europe(00:16:30) - Former Intuitive EVP Brian Miller joins Sovato as CEO(00:21:18) - Former Baxter CEO takes the corner office at Hologic as go-private deal closes(00:26:20) - Keynote interview: Eric Timko, CEO, OrthAlign -
In this episode of the DeviceTalks Weekly podcast, Amaza Reitmeier shares with Host Tom Salemi why she left the company she never thought she’d leave — Medtronic — to lead Pharaoh Neuro, a company developing a novel approach to treating stroke patients by removing harmful blood from cerebrospinal fluid. Reitmeier shares lessons from her own career and her mentors on timing big moves, learning what you don’t know, and why some of MedTech’s biggest opportunities remain hidden in plain sight.
This episode is sponsored by DeviceTalks Minnesota. Register at Minnesota.DeviceTalks.com and use the code DTW25 to save 25% off the registration fee.
Salemi and MassDevice Editor Chris Newmarker offer encouragement to exercising listeners while delivering this week’s Newmarker’s Newsmakers — including updates on cardiology companies, HistoSonics, Boston Scientific, Johnson & Johnson MedTech, Abbott, the Mayo Clinic, and WHOOP.
***
Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.
Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe
Chapters(00:08:12) - The biggest cardiology tech stories out of ACC 2026(00:11:45) - HistoSonics kicks off study using Edison histotripsy system in BPH(00:14:20) - Boston Scientific completes Valencia Technologies acquisition(00:16:00) - Johnson & Johnson MedTech shares findings for Impella CP in left ventricle support(00:16:27) - Abbott joins $575M funding round for wearable maker WHOOP(00:22:20) - Keynote Interview, Amaza Reitmeier, CEO, Pharaoh Neuro -
In this episode of DeviceTalks Weekly, Medtronic’s Blake Tatum, Vice President of U.S. Commercial for Acute Care & Monitoring, joins Host Tom Salemi to unpack the evolving patient monitoring landscape. Tatum shares how Medtronic is integrating sensors, data, and digital health to support clinicians from the ICU to the home, why partnerships are reshaping the competitive playbook, and how lessons from the pandemic are driving a new focus on accuracy, equity, and connectivity in care delivery.
This episode is sponsored by DeviceTalks Minnesota. Go to Minnesota.Devicetalks.com to check out the amazing agenda!
Then Salemi and MassDevice editor Chris Newmarker review this week’s MedTech newsmakers including surgical robotics, Abbott, Stryker, Boston Scientific, and Medtronic.
***
Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.
Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe
Chapters(00:05:15) - 10 surgical robotics companies you need to know (Go to MassDevice.com to download the report)(00:08:09) - Abbott completes Exact Sciences acquisition(00:09:37) - Stryker reportedly brings most services affected by cyberattack back online(00:11:20) - Boston Scientific has reportedly had pacemaker battery problems for years(00:14:01) - Round up of Medtronic News(00:21:30) - Keynote interview with Medtronic’s Blake Tatum -
In this episode of DeviceTalks Weekly, Distalmotion CEO Greg Roche updates Host Tom Salemi on the surgical robotics company’s commercial roll out of Dexter, a robotic system designed for ambulatory surgery centers. Roche shares the lessons he’s learned after a decade in surgical robotics and why he’s particularly optimistic about his company’s outcome.
You can hear Greg Roche’s first appearance on the podcast right here: https://www.devicetalks.com/why-distalmotions-roche-sees-dexters-small-size-as-big-advantage-in-the-robotics-surgical-market/
This episode is sponsored by DeviceTalks Boston. Register at Boston.DeviceTalks.com. Use the code DTW25 to save 25% off the registration price.
Rachel Robinson, COO of MassMEDIC, joins the MassDevice Newmarker’s Newsmakers with Salemi and Editor Chris Newmarker – Stryker, CMR Surgical, Revolve Surgical, JenaValve, and MassDevice’s Surgical Robotics Special Report for 2026. You can download the report with 70+ profiles of surgical robotics companies here - https://www.massdevice.com/surgical-robotics-special-report-2026/
Robinson also welcomes listeners to attend MassMEDIC’s Symposium & Gala on April 2. Go to MassMEDIC.com to see the agenda and to register.
***
Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.
Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe
Chapters(00:04:15) - MassMEDIC COO Rachel Robinson discusses the Medtech Impact Symposium & Gala(00:10:05) - MassDevice’s Surgical Robotics Special Report for 2026(00:11:58) - Stryker CEO Kevin Lobo joins GE HealthCare board of directors(00:14:35) - CMR Surgical, Nvidia collab to train next-gen surgical robots(00:18:02) - Revolve Surgical wins FDA clearance for surgical robot(00:21:00) - JenaValve wins FDA nod for Trilogy heart valve system(00:35:45) - Keynote Interview – Greg Roche, CEO, Distalmotion -
In this episode of the DeviceTalks Weekly podcast, Stephen From, the new CEO of Vicarious Surgical, explains why he jumped the chasm from biotech to lead surgical robotics company Vicarious Surgical. From brings years of experience bringing products to market and he lays out the plan for Vicarious’s single-incision robot to Host Tom Salemi.
Next, Salemi interviews Bill Frey, Regional Sales Engineer, Harmonic Drive, about the unique challenges of surgical robotics. For more information about Harmonic Drive, go to www.harmonicdrive.net.
But we’ll start off with Salemi and MassDevice Editor Chris Newmarker discussing this week’s Newmarker’s Newsmakers – Petal Surgical, Abbott, Stryker, and Medtronic.
***
Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.
Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe
Chapters(00:02:50) - Chris and Tom talk turkeys(00:06:20) - Incisionless surgical robot developer Petal Surgical adds more funding, Fred Moll joins board(00:09:50) - Abbott completes $20B offering for Exact Sciences buy(00:12:02) - Stryker launches SmartHospital platform to elevate care delivery(00:15:00) - Stryker reportedly hit with Iran-backed cyberattack(00:16:41) - Medtronic makes neurovascular play with $550M Scientia Vascular buy(00:18:55) - FOMO - Bill Frey, Regional Sales Engineer, Harmonic Drive(00:30:05) - Keynote Conversation, Stephen From, CEO, Vicarious Surgical -
In this episode of the DeviceTalks Weekly podcast, Jessica Mathieson, president of Stryker’s medical business, takes Host Tom Salemi to the frontlines of healthcare, where hospitals are seeking support for healthcare professionals. Mathieson will explain how the acquisitions of Vocera and Care AI have enabled Stryker to build a comprehensive communications and monitoring tool that can keep nurses safe while improving patient care.
Find Mathieson’s first visit to DeviceTalks here: https://www.stryker.com/us/en/about/news/2022/acute-care-s-mathieson-explains-how-vocera-fits-into-stryker-s-g.html
And as an added bonus, on Monday, March 9th, Stryker announced that it launched its new SmartHospital platform. Learn more here: https://www.massdevice.com/stryker-launches-smarthospital-platform-care-delivery/
In this week’s FOMO, Ignacio Pedrosa, Advanced Solutions Engineer at Novanta, talks with Kayleen Brown about the company’s work to make surgical robotic systems smaller, smarter and more capable. For more information, go to https://novanta.com.
In this week’s Newmarker’s Newsmakers, MassDevice Editor Chris Newmarker and Salemi talk about their favorite flavor of Girl Scout cookie. (Buy yours in the link below) before talking about the top stories of the week – Smith & Nephew, Science Corp., Boston Scientific, Medtronic and, in a bit of Meta-ness – an article about Jenny Barba’s appearance on the podcast two weeks ago!
Go here to buy cookies from Chris’s daughter! - https://digitalcookie.girlscouts.org/scout/stella590572
***
Chapters(00:05:42) - Smith+Nephew posts Q4 sales beat amid overall strategy shift(00:07:39) - 3 tips for first-time medtech entrepreneurs from a venture capital pro(00:09:51) - Science Corp. closes $230M Series C to support BCI tech(00:13:27) - Boston Scientific wins expanded CE mark for Farapulse in persistent AFib(00:17:01) - Medtronic, GE HealthCare expand strategic alliance(00:20:57) - FOMO – Ignacio Pedrosa, Advanced Solutions Engineer, Novanta(00:33:18) - Keynote Interview, Jessica Mathieson, President, Medical at Stryker
Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.
Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe -
In this episode, Armor Medical Co-founder and CEO Kelsey Mayo shares her ultimate entrepreneurial journey. Mayo recognized early on that her career needed to make an impact, but the focus of her passion became clear after a frightening experience of her own. Today, she’s CEO of a startup building a wearable device that can serve as an early warning system for hemorrhaging. This could immediately protect the lives of women giving birth and ultimately replace guesswork with irrefutable data. Armor Medical won MedTech Innovator’s top award at AdvaMed in the fall.
This episode is sponsored by DeviceTalks Minnesota.
Speaking of MedTech Innovator, CEO Paul Grand joins Tom Salemi and Chris Newmarker to analyze this week’s top Newsmakers from MassDevice — DePuy Synthes, Medtronic, Pharaoh Neuro, Stryker, and Boston Scientific.
Grand also introduced MedTech Innovator’s Radar Forum:
https://medtechinnovator.org/radarforum2026/***
Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.
Chapters(00:03:30) - MedTech Innovator Radar Forum(00:12:06) - Pharaoh Neuro raises $20M, names former Medtronic exec as CEO(00:15:05) - Medtronic MiniMed Diabetes unit prices IPO at up to $784M(00:20:40) - Medtronic wins CE mark for next-gen GI Genius module, ColonPRO software(00:22:50) - AHA, ACC issue guidelines for pulmonary embolism that affect Boston Scientific, Stryker(00:24:56) - Johnson & Johnson MedTech reportedly eyes $20B deal to sell DePuy Synthes ortho unit(00:34:13) - Keynote interview: Kelsey Mayo, Co-founder and CEO, Armor Medical
Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe -
In this episode of DeviceTalks Weekly, Managing Editor Kayleen Brown takes the helm, leading a keynote interview with Jenny Barba, co-founder of Features Capital. Barba shares her path into venture capital, identifies winning strategies for start-ups, and highlights some of the more exciting companies in the Features Capital portfolio.
A special thanks to this episode’s sponsor, SHL Healthcare, for supporting DeviceTalks! Go to www.shl-healthcare.com for more information. As a special bonus, download SHL Healthcare's complimentary white paper highlighting the outcomes of using the combination of advanced sewing, welding, and electromechanical assembly here: https://www.devicetalks.com/wp-content/uploads/2026/02/SHL-Healthcare_Whitepaper_Integrated-Approach.pdf
Kayleen Brown also leads our FOMO interview with Nick West, MD, chief medical officer of Shockwave Medical, part of Johnson & Johnson MedTech. They talk about the future calcium modification, intravascular lithotripsy, and the evolving treatment of vascular disease.
We’ll start things off with Host Tom Salemi and Chris Newmarker of MassDevice reviewing the newsmakers of the week - BioVentrix, Medical 21, VB Spine, Augmedics, Medtronic, Danaher, and Masimo.
***
Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.
Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe
Chapters(00:06:47) - #5 BioVentrix & Medical 21 IPOs(00:10:24) - #4 VB Spine acquires Augmedics(00:11:35) - #3 Medtronic Stealth Access robotic system(00:13:14) - #4 Medtronic earnings & growth updates(00:17:00) - #1 Danaher to acquire Masimo(00:23:15) - FOMO Interview – Nick West, MD, Chief Medical Officer, Shockwave Medical, part of Johnson & Johnson MedTech(00:23:42) - Part 1 of our interview with Per Bjorkman, Chief Commercial Officer, SHL Healthcare(00:41:31) - Keynote Interview, Jenny Barba, co-founder, Features Capital -
In this episode of DeviceTalks Weekly, Host Tom Salemi speaks with MedTech veteran Darrin Uecker about a career shaped by some of the industry’s most notable innovations and acquisitions.
Uecker’s journey begins at Computer Motion, where he served as CTO through its historic acquisition by Intuitive Surgical. He recounts how that deal came together and traces the path that led him to senior leadership roles at multiple startups that ultimately achieved successful exits.
Today, Uecker is chief technology officer at Pulse Biosciences, a small publicly traded company developing a next generation of pulsed-field ablation technology. He discusses the unconventional steps Pulse has taken to build its business, reviews the company’s latest clinical data, and shares his perspective on the future of the fast-moving PFA market.
In our FOMO Interview, Ralph Kern, MD, chief medical officer of neuro startup Cognito Therapeutics, explains why he’s excited about technical advances in the field. He’s interviewed by Jim Hammerand, managing editor at Medical Design & Outsourcing magazine.
As always we start the episode with MassDevice Editor Chris Newmarker and his top 5 stories of the week….aka Newmarker’s Newsmakers.
Thank you for listening to DeviceTalks Weekly!
***
Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.
Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe
Chapters(00:04:15) - Karl Storz, Smith+Nephew partner on advanced surgical tech(00:06:32) - NextSense debuts brain activity-sensing headphones to improve sleep(00:11:17) - Medtronic stock gets a ratings boost on new products(00:12:40) - Johnson & Johnson MedTech has encouraging Omnypulse results, more data backs Varipulse(00:14:35) - Stryker says DOJ, SEC have closed bribery probes(00:16:40) - FOMO Interview – Ralph Kern, MD, Chief Medical Officer, Cognito Therapeutics(00:28:15) - Keynote Interview – Darrin Uecker, Chief Technology Officer, Pulse Biosciences(00:48:05) - The Pulse Biosciences stor -
In this episode of DeviceTalks Weekly, CathWorks CEO Ramin Mousavi explains how the company built a surprisingly fast path to acquisition.
Founded in 2013, the startup was forced to go back to the drawing board. By incorporating LLMs and other advances, CathWorks developed a better way to diagnose heart disease—leading to a strategic investment from Medtronic in 2022 and a full acquisition announced this week.
Mousavi also shares his personal path into MedTech, including the unlikely story of an Iranian-American leading an Israel-based startup. In a conversation with Host Tom Salemi, he reflects on how employees kept the company’s mission front and center through constant change.
In this week’s FOMO, Managing Editor Kayleen Brown draws on her own experience with Type 2 diabetes to explore how Dexcom is using data and AI. She speaks with Girish Naganathan, EVP and Chief Technology Officer at Dexcom.
Plus, MassDevice Editor Chris Newmarker delivers Newmarker’s Newsmakers, featuring Medtronic, Siemens Healthineers, Stryker, Boston Scientific, and Applied Medical.Thank you for listening to DeviceTalks Weekly!
***
Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.
Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe
Chapters(00:02:38) - State of Minnesota / Newmarker’s Newsmakers(00:08:00) - Medtronic Structural Heart President Nina Goodheart to retire(00:09:11) - Siemens Healthineers unveils $12M R&D facility in Ireland(00:12:10) - Stryker officials have high hopes for 2026 with Mako RPS(00:13:54) - Boston Scientific posts Q4 beats as sales rise 16%, stock dips as EP sales come up short(00:16:19) - Medtronic reportedly must pay Applied Medical $382M over antitrust suit(00:21:52) - FOMO Interview – Girish Naganathan, EVP, Chief Technology Officer, Dexcom(00:32:28) - Keynote Interview – Ramin Mousavi, President, CEO, CathWorks -
In this week’s episode of DeviceTalks Weekly, neurosurgeon Adam Arthur, MD, explains why he’s trading surgical scrubs for the chance to help lead Medtronic’s Neurovascular business as its new chief medical officer. Dr. Arthur joins Host Tom Salemi to discuss how neurosurgery is reaching more patients today—and what it must do to expand its impact in the years ahead.
Before the keynote interview, Managing Editor Kayleen Brown speaks with Brittany Mai of Confluent Medical Technologies about the future of neuro and minimally invasive surgery. Thank you to Confluent for sponsoring this week’s episode. Learn more at ConfluentMedical.com.
At the top of the show, MassDevice Editor Chris Newmarker talks with Wayne Paterson, CEO of Anteris Technologies, about the company’s new agreement with Medtronic and what it means for the future of TAVR.
Thank you for listening to DeviceTalks Weekly!
***
Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.
Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe
Chapters(00:03:38) - Chris Newmarker interviews Wayne Paterson, CEO of Anteris Technologies(00:06:10) - This is not your Father’s TAVR(00:08:00) - Terms of the Medtronic investment(00:25:30) - Kayleen Brown sits down with Brittany Mai of Confluent Medical(00:29:50) - How is minimally invasive technology changing?(00:31:28) - Keynote conversation – Adam Arthur, MD, new chief medical officer for Medtronic Neurovascular(00:35:30) - What makes a good neurosurgeon?(00:39:01) - Choosing impact over intimacy(00:44:50) - What do patients fear more than death?(00:49:45) - More focus needed on Women’s neurological health including chronic refractory migraine - Visa fler
